These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 19380700)

  • 1. Age-associated leukoaraiosis and cortical cholinergic deafferentation.
    Bohnen NI; Müller ML; Kuwabara H; Constantine GM; Studenski SA
    Neurology; 2009 Apr; 72(16):1411-6. PubMed ID: 19380700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mapping of brain acetylcholinesterase alterations in Lewy body disease by PET.
    Shimada H; Hirano S; Shinotoh H; Aotsuka A; Sato K; Tanaka N; Ota T; Asahina M; Fukushi K; Kuwabara S; Hattori T; Suhara T; Irie T
    Neurology; 2009 Jul; 73(4):273-8. PubMed ID: 19474411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. White matter hyperintensities and cortical acetylcholinesterase activity in parkinsonian dementia.
    Marshall GA; Shchelchkov E; Kaufer DI; Ivanco LS; Bohnen NI
    Acta Neurol Scand; 2006 Feb; 113(2):87-91. PubMed ID: 16411968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. 17beta-estradiol enhances cortical cholinergic innervation and preserves synaptic density following excitotoxic lesions to the rat nucleus basalis magnocellularis.
    Horvath KM; Hårtig W; Van der Veen R; Keijser JN; Mulder J; Ziegert M; Van der Zee EA; Harkany T; Luiten PG
    Neuroscience; 2002; 110(3):489-504. PubMed ID: 11906788
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new visual rating scale to assess strategic white matter hyperintensities within cholinergic pathways in dementia.
    Bocti C; Swartz RH; Gao FQ; Sahlas DJ; Behl P; Black SE
    Stroke; 2005 Oct; 36(10):2126-31. PubMed ID: 16179569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cholinergic denervation occurs early in Parkinson disease.
    Bohnen NI; Albin RL
    Neurology; 2009 Jul; 73(4):256-7. PubMed ID: 19535769
    [No Abstract]   [Full Text] [Related]  

  • 7. Frontal and periventricular brain white matter lesions and cortical deafferentation of cholinergic and other neuromodulatory axonal projections.
    Bohnen NI; Bogan CW; Müller ML
    Eur Neurol J; 2009 Sep; 1(1):33-50. PubMed ID: 22763426
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Acute cholinergic rescue of synaptic plasticity in the neurodegenerating cortex of anti-nerve-growth-factor mice.
    Pesavento E; Capsoni S; Domenici L; Cattaneo A
    Eur J Neurosci; 2002 Mar; 15(6):1030-6. PubMed ID: 11918663
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Developmental origins of the age-related decline in cortical cholinergic function and associated cognitive abilities.
    Sarter M; Bruno JP
    Neurobiol Aging; 2004 Oct; 25(9):1127-39. PubMed ID: 15312959
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective cholinergic lesions in the rat nucleus basalis magnocellularis with limited damage in the medial septum specifically alter attention performance in the five-choice serial reaction time task.
    Harati H; Barbelivien A; Cosquer B; Majchrzak M; Cassel JC
    Neuroscience; 2008 Apr; 153(1):72-83. PubMed ID: 18339485
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cerebral amyloid angiopathy burden associated with leukoaraiosis: a positron emission tomography/magnetic resonance imaging study.
    Gurol ME; Viswanathan A; Gidicsin C; Hedden T; Martinez-Ramirez S; Dumas A; Vashkevich A; Ayres AM; Auriel E; van Etten E; Becker A; Carmasin J; Schwab K; Rosand J; Johnson KA; Greenberg SM
    Ann Neurol; 2013 Apr; 73(4):529-36. PubMed ID: 23424091
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of strategic white matter hyperintensities of cholinergic pathways on basal forebrain volume in patients with amyloid-negative neurocognitive disorders.
    Kim YE; Lim JS; Suh CH; Heo H; Roh JH; Cheong EN; Lee Y; Kim JW; Lee JH
    Alzheimers Res Ther; 2024 Aug; 16(1):185. PubMed ID: 39148136
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Microsphere embolism-induced cortical cholinergic deafferentation and impairments in attentional performance.
    Craft TK; Mahoney JH; Devries AC; Sarter M
    Eur J Neurosci; 2005 Jun; 21(11):3117-32. PubMed ID: 15978021
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Patterns of white matter hyperintensities associated with cognition in middle-aged cognitively healthy individuals.
    Brugulat-Serrat A; Salvadó G; Sudre CH; Grau-Rivera O; Suárez-Calvet M; Falcon C; Sánchez-Benavides G; Gramunt N; Fauria K; Cardoso MJ; Barkhof F; Molinuevo JL; Gispert JD;
    Brain Imaging Behav; 2020 Oct; 14(5):2012-2023. PubMed ID: 31278650
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Progressive loss of cortical acetylcholinesterase activity in association with cognitive decline in Alzheimer's disease: a positron emission tomography study.
    Shinotoh H; Namba H; Fukushi K; Nagatsuka S; Tanaka N; Aotsuka A; Ota T; Tanada S; Irie T
    Ann Neurol; 2000 Aug; 48(2):194-200. PubMed ID: 10939570
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Do lesions involving the cortical cholinergic pathways help or hinder efficacy of donepezil in patients with Alzheimer's disease?
    Fukui T; Hieda S; Bocti C
    Dement Geriatr Cogn Disord; 2006; 22(5-6):421-31. PubMed ID: 16974095
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Proteasomal abnormalities in cortical Lewy body disease and the impact of proteasomal inhibition within cortical and cholinergic systems.
    MacInnes N; Iravani MM; Perry E; Piggott M; Perry R; Jenner P; Ballard C
    J Neural Transm (Vienna); 2008 Jun; 115(6):869-78. PubMed ID: 18401540
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterising the grey matter correlates of leukoaraiosis in cerebral small vessel disease.
    Lambert C; Sam Narean J; Benjamin P; Zeestraten E; Barrick TR; Markus HS
    Neuroimage Clin; 2015; 9():194-205. PubMed ID: 26448913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Donepezil induces a cholinergic sprouting in basocortical degeneration.
    Ginestet L; Ferrario JE; Raisman-Vozari R; Hirsch EC; Debeir T
    J Neurochem; 2007 Jul; 102(2):434-40. PubMed ID: 17394553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Progression of white matter hyperintensities and incidence of new lacunes over a 3-year period: the Leukoaraiosis and Disability study.
    Gouw AA; van der Flier WM; Fazekas F; van Straaten EC; Pantoni L; Poggesi A; Inzitari D; Erkinjuntti T; Wahlund LO; Waldemar G; Schmidt R; Scheltens P; Barkhof F;
    Stroke; 2008 May; 39(5):1414-20. PubMed ID: 18323505
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.